BRL), and 10% heat-inactivated normal human serum (NHS). All media were endotoxin free. The recombinant human cytokines were: c-kit ligand (KL; or stem cell factor, SCF; Amgen, Thousand Oaks, CA) 20 ng/mL; GM-CSF (gift of Kirin Brewery, Maebashi, Gunma, Japan) 100 ng or 1, OOO U/mL; TNF-a (R&D Systems, Minneapolis, MN) 10 ng or 1,000 U/mL; M-CSF (Cetus, Oakland, CA) 1, OOO U/ mL. Culture of human CD34+ progenitors in suspension and colonyforming assays. Suspension cultures of CD34+ BM cells were initiated with complete IMDM-20% FCS at an initial concentration of 2 x 10s celld5 mL in 35-mm tissue-culture wells (#25810-6; Corning Costar Corp, Cambridge, MA), supplemented with c-kit ligand, GM-CSF, and TNF-a. Intermediate populations were isolated as described below. Cells were recultured at -1 X 105/mL in IMDM-20% FCS with the cytokines indicated for a particular experiment, but without c-kit ligand. Lower yields were scaled down to proportionally smaller volumes and wells for reculture. Medium and cytokines were neither changed nor replenished at any time, except when the sorted populations were recultured.
Colony-forming assays were performed in triplicate in 0.36% agarose (FMC Bioproducts, Rockland, ME) and complete IMDM-20% FCS, starting with 1 to 2 X lo3 CD34+ cells in 1-mL cultures; or in microwells with cells seeded at limiting dilution in IMDM-20% FCS. CFus were quantified by counting colonies of 2 5 0 cells.
All cultures were maintained at 37°C in humidified 5% CO,.
Monoclonal antibodies (MoAbs), cell phenotype analysis, and cytochemical staining. Murine antihuman MoAbs were used either as purified Igs or as hybridoma supernatants (Table 1 ). In some cases the MoAbs were conjugated with either fluorescein isothiocyanate (FITC) or phycoerythrin (PE). Otherwise, FITC-conjugated F(ab); goat-antimouse IgG + IgM (Boehringer Mannheim, Indianapolis, IN) or PE-conjugated F(ab); goat-antimouse IgG (TAGO, Burlingame, CA) was used as a second-step reagent for indirect staining. For three-color cytofluorographic evaluations, PerCP-conjugated anti-HLA-DR (Becton Dickinson [BD], San Jose, CA) was used. Stained cells were analyzed by cytofluorography on a FACScan (BD). Nonreactive MoAbs of the same isotype and subclass were used as controls. Cytospins were made for Wright-Giemsa and cytochemical staining for nonspecific esterase (NSE; a-naphthyl butyrate esterase; Sigma], specific esterase (naphthol AS-D chloroacetate esterase; Sigma), and myeloperoxidase (Sigma).".14 Ki-67 and c-fms were detected on cytospins using a standard immunoperoxidase staining method.14 Isolation of CD14+ HLA-DR+ intermediates from suspension cultures of normal human CD34' BM precursors. The bulk progeny Allogeneic mixed leukocyte reaction ( M U ) and aCD3 polyclonal mitogenesis. Antigen-presenting cells (APCs: blood dendritic cells, blood monocytes, and marrow-derived CD34+ progeny cells) were added in graded doses to primary allogeneic T cells in 96dcrowell tissue culture plates (1 x l@ T celldround-bottomed microwell). APCs expanded from CD34' BM precursors were thoroughly washed free of cytokine and irradiated 1,500 rads ["'Cs] before addition. Logistically we could not obtain blood dendritic cells and monocytes from the same donors from whom CD34' progenitors had been obtained. Therefore, the blood dendritic cells andor monocytes used for comparison of accessory function with the marrowderived APCs were from a different donor than the BM progeny. T-cell responders were always from a single donor for a given experiment. The capacity for an APC population to support FcR-mediated anti-CD3 polyclonal mitogenesis was assessed in similar MLRs where OKT3 (1 pg/mL final; Orthoclone OKTa3, gift of Ortho Biotech, Raritan, NJ) was added.
Cultures were pulsed for 8 to 12 hours with 1 pCi/well of 3Hthymidine ('HTdR; New England Nuclear, Boston, MA) beginning 60 to 72 hours from the start of culture for anti-CD3 mitogenesis, and beginning -days 4 to 5 for the allogeneic MLRs. To discount any increased proliferation caused by allodisparities in the MLR during anti-CD3 mitogenesis, an allogeneic MLR was cultured and pulsed in parallel with proliferation subtracted from that in the OKT3 plates. The amount of 'HTdR incorporated by the responder T cells was plotted against the dose of stimulator cells as a measure of stimulatory capacity. Responses have been reported as the mean cpm 2 SD of triplicates. Wells containing only T cells or only APCs (1,500 rads "'Cs) always incorporated less than 500 cpm 'HTdR.
FITC-conjugated latex particles (Fluoresbrite, 0.2-pm microspheres, 2.5% solids, 100 X stock, cat no. 17151; Polysciences, Inc, Wanington, PA) were added to cells in a final volume of 100 pL medium with 10% FCS. The optimal cell concentration was 5 to 10 X 104/100 pUround-bottomed microwell, and the minimum concentration was 2 x 1o4/microwell. Positive controls were cultured blood monocytes. Negative controls to determine background fluorescence were cells to which FITC-latex beads were not added, as well as nonphagocytic cells (eg, T lymphocytes) with FITC-latex beads. Cells were incubated in the microwell plate for 1 hour at 37°C in humidified 5% COz. Cells were then washed five times while still in the microwell plate using cold buffer of choice, with intervening 3-minute centrifugations at 400 g at 4°C. Cells were analyzed by cytofluorography.
Phagocytosis assays.

RESULTS
Serial phenotype of human CD34+ BM-derived progeny in suspension cultures supplemented with GM-CSF and TNF-a. CD34+ BM precursors were
merited With 20% FCS and c-kit ligand, GM-CSF, and TNF- 1, day 6 ). The presort panning depletion proved essential to observe dendritic cell development from the sorted CD 14+ HLA-DR+ fraction, because macrophages that had already matured also adhered nonspecifically alongside anti-CD34 opsonized cells (see also Results).
PB mononuclear cells (PBMC) and enrichment of blood dendritic cells, monocytes, and T lymphocytes.
Mononuclear cells were prepared from buffy coats according to previously published procedures to obtain primary leukocyte subpopulations of T cells, monocytes, and dendritic cells.18-21 cells with the CD14-HLA-DR+++ phenotype began to develop between days 2 and 4 of suspension culture and were well-established by day 6 (Fig 1) . A subpopulation of CD14' HLA-DR+ cells was also identifiable by day 6 (Fig 1) . Phenotypically and quantitatively similar populations were present at days 12 through 14. The increasing proportion of CD14-HLA-DR-cells in the bulk day 12 progeny represented granulocytic precursors, owing to the effect of ckit ligand.13 Based on these cytofluorographic studies we presumed that the CD14+ HLA-DR+ cells were macrophages, and the CD14-HLA-DR+++ cells were dendritic cells. As became evident after more detailed evaluation, the latter proved to be the case, but the aforementioned CD14+
For personal use only. on January 1, 2018. by guest www.bloodjournal.org From HLA-DR+ cells were quite different from mature monocytes/ macrophages and actually proved to be bipotential with respect to subsequent terminal differentiation.
Ident$cation of mature, CD14-HLA-DR+++, dendritic cells in the day 6progeny of CD34+ precursors. Cells with the markers of mature dendritic cells, ie, CD14-and HLA-DR+++, constituted 2.1% 2 1.1% (n = 12, 5 of which were analyzed in duplicate) of the bulk day 6 progeny. The percent yield of these CD14-, intensely HLA-DR+++ cells did not increase with an additional week of culture. The population was sorted using the gate indicated in Fig 1 for more detailed morphologic, cytochemical, and phenotypic characterization. Cytospins of the sorted population showed cells with cytoplasmic veils and processes that typify dendritic cells. These cells did not stain for myeloperoxidase or specific (naphthol AS-D chloroacetate) esterase, and were predominantly negative for nonspecific (a-naphthyl-butyrate) esterase, as previously reported for day 12 through 14 progeny of the same phenotype." This CD14-HLA-DR'" fraction expressed CDla, CD83, CD4, CD45RO > CD45RA. CDI 1 a,b,c, CD 18, CD40, CD54, CD58, CD80, CD86, and CD74; c-jins was absent ( Table 1 ). These phenotypic criteria distinguished the day 6 CD14-HLA-DR"' cells as candidate dendritic cells.
The day 6 CD14-HLA-DR'" progeny were also tested as stimulators in an allogeneic MLR, an assay that highlights the specialized stimulatory properties of dendritic cells. CD14-HLA-DR"' cells were sorted as above, irradiated, and added in serial doses to resting allogeneic T cells for 4 to 5 days. Stimulatory capacity was potent and comparable to that exerted by blood dendritic cells (Fig 2) . At least one log fewer CD14-HLA-DR"' cells stimulated the same degree of responder T cell proliferation as that effected by the presort population. These morphologic, cytochemical, phenotypic, and functional criteria indicated that mature CD14-HLA-DR"' dendritic cells had developed by day 6 from human CD34' BM cells under these culture conditions.
The CD14-HLA-DR' cells present at day 6 were also examined for the possibility that these might be less mature dendritic cells. This was not pursued further because this fraction consisted predominantly of immature myeloid cells that differentiated primarily into granulocytes and macro-phages. Few if any additional dendritic cells were generated, irrespective of reculture in GM-CSF and TNF-a.
Properties of day 6 CD14' HU-DR' progeny derived
from human CD34' BM precursors. Day 6 progeny of CD34' BM cells cultured in c-kit ligand, GM-CSF, and TNF-a were depleted of persisting CD34' HLA-DR' precursor populations by panning. Losses exceeded the few CD34' cells known still to be present at day 6," and averaged 22% % 17% (n = IO). Panning did not remove the CD14-HLA-DR"' dendritic cells. Most of the cells that had attached during CD34' panning were well spread, firmly adherent, and morphologically typical of macrophages. Functional assays were confirmatory because the attached cells supported vigorous FcR-mediated mitogenesis with anti-CD3 but weak allogeneic MLRs'' (not shown).
Further characterization of the CD14' HLA-DR' cells was undertaken after panning. These cells constituted 18% & 4% (n = 11, 6 of which were analyzed in duplicate) of the pan nonadherent day 6 cultures and were sorted using the gate shown in Fig 1. This population had features that were atypical of either terminally differentiated macrophages or dendritic cells. The cells did not stain for myeloperoxidase or specific (naphthol AS-D chloroacetate) esterase, and were predominantly nonspecific (a-naphthyl butyrate) esterase
For personal use only. on January 1, 2018. by guest www.bloodjournal.org From pared with blood dendritic cells and macrophages. The macropotent allogeneic stimulators, although intermediate between the presort population and either blood dendritic cells or the sorted CD14-HLA-DR"' dendritic cells derived from the same CD34' precursors. Their potency exceeded that of cultured blood monocytes/macrophages by several logs.
In contrast were their phagocytic properties. When exposed to 0.2 pm FITC-conjugated latex particles, the day 6 sorted CD14' HLA-DR+ cells were comparably phagocytic to cultured blood monocytes, although their background control was somewhat higher (Fig 3, top) . Mature blood dendritic cells are not actively phagocytic."
The CD14+ HLA-DR+ cells were also examined for a panel of surface markers (Table I ). The bulk day 6 pan nonadherent cells were analyzed by three-color cytofluorography, and sorted cells were cytocentrifuged onto glass slides for staining. The profile of these cells was notable for the phage-depleted, day 6 CD14+ HLA-DR' cells proved to be negative. The cells did not attach to plastic, but exhibited many processes, including large lamellipodia or veils. Forty to 50% of the cells expressed the Ki-67 nuclear antigen of cycling cells and had limited proliferative potential in the presence of M-CSF (see below). However, these cells no longer had colony-forming capacity in clonogenic assays in the presence of either GM-CSF and TNF-a, or M-CSF alone.
The day 6 CD14+ HLA-DR+ cells were further evaluated for allostimulatory function and phagocytic capacity, and com- For personal use only. on January 1, 2018. by guest www.bloodjournal.org From presence of c-fms, the receptor for M-CSF, and the absence of the dendritic cell marker CD83, as well as the rarity of CDla and the CD80/CD86 B7 costimulator molecules. The cells uniformly expressed readily detectable levels of CD4, CDlla,b,c, CD18, CD32, CD64, CD40, CD54, and CD58. Therefore, these data indicated that despite their c-fms+ CD 14' HLA-DR+ phenotype and phagocytic activity, these cells differed with respect to a number of important monocyte features. Similarly, these cells could not be classified as mature dendritic cells, as were their CD14-HLA-DR+++ counterparts. Given this lack of identifiable commitment to either the monocytic or dendritic cell lineage, it was investigated whether these CD14+ HLA-DR+ cells constituted intermediates whose terminal differentiation could be experimentally altered by selective cytokine exposure during subsequent in vitro reculture.
Log, fluorescence
Contrasting differentiation of double-positive CD14+ HLA-DR+ intermediates recultured in GM-CSF and TNF-a versus M-CSF. The day 6 pan nonadherent, sorted, double-positive CD14+ HLA-DR+ cells were recultured in either GM-CSF and TNF-a, or M-CSF, for an additional 6 to 7 days. After a total of 12 to 14 days in suspension culture, including the initial 6 days of culture in KL, GM-CSF, and TNF-a, the progeny of the second week's multure were harvested and manually counted to ensure viability by trypan blue exclusion. The cells were then phenotyped and evaluated in functional assays for their stimulatory and phagocytic properties.
Those CD 14" HLA-DR+ cells recultured in GM-CSF and TNF-a were nonadherent, motile, and displayed prominent cytoplasmic veils in suspension culture ( Fig 4A) and dendrites on cytocentrifuged preparations ( Fig 4B) . They lost CD14 and c-fms, whereas class I1 MHC expression was upregulated ( Fig 5A) . In addition, all acquired CD80 and CD86 ( Fig 5B) , most expressed CDla and CD83 (Fig 5B) , and a minority had nonspecific (a-naphthyl butyrate) esterase activity (not shown).
The same double-positive cells recultured from day 6 + days 12 through 14 in M-CSF were mostly adherent without cytoplasmic veils or processes (Fig 4C and D) and retained CD14, c-fms, and class I1 MHC expression ( Fig 5A) . The cells also expressed B7-2/CD86 but at a lower intensity than their counterparts recultured in GM-CSF and TNFa; CDla, CD83, and B7-1/CD80 were all absent ( Fig 5B) . Nonspecific (a-naphthyl butyrate) esterase was also present (not shown).
In addition to phenotypic alterations, GM-CSF and TNFa fostered the development of stimulatory function that was comparable with that of mature blood dendritic cells ( Fig 6) . In contrast, double-positive CD14+ HLA-DR' intermediates lost stimulatory activity for resting allogeneic T cells when recultured in M-CSF.
The converse was true of phagocytosis. CD14' HLA-DR+ intermediates became less phagocytic after reculture in GM-CSF and TNF-a. CD14+ HLA-DR+ intermediates recultured in M-CSF became more actively phagocytic. In fact, their phagocytic capacity for FITC-conjugated latex beads exceeded that of their counterparts recultured in GM-CSF and TNF-a by at least 10-fold (Fig 3, bottom) .
These same CD14+ HLA-DR' intermediates were also recultured in GM-CSF alone (not shown). In the absence of TNF-a, the maturing cells were more heterogeneous. Fewer cells developed the characteristic veils of dendritic cells, allostimulatory function was weaker although still in excess of intermediates recultured in M-CSF, and phenotypic loss of CD14 was incomplete.
To ensure that differences in functional maturation were not caused by differences in plastic adherence, the doublepositive intermediates were recultured in Teflon beakersz3 with the same cytokines. Cells recultured in M-CSF retained all the features of plastic adherent macrophages, including very poor MLR stimulatory activity. Intermediates recultured in GM-CSF and TNF-a were also no different from their counterparts on tissue culture plastic.
The sorted CD14' HLA-DR' intermediates were irradiated or not before reculture to investigate whether a proliferating subpopulation had a survival advantage without changing the net yield. However, differentiation along either pathway was not altered by irradiation before reculture in the respective cytokine conditions (Figs 5 and 6 ).
The expression of the Ki-67 nuclear antigen by 40% to 50% of the day 6 sorted CD14+ HLA-DR+ fraction was indicative that these cells were still in cycle, despite their loss of clonogenic potential. However, no further rounds of cell division occurred when the CD14+ HLA-DR+ intermediates were recultured in GM-CSF and TNF-a. Expansion was maximally -2.5-fold after reculture in M-CSF. Reculture in IMDM-20% FCS in the absence of exogenous cytokines generated cells like those from M-CSF-supplemented cultures (Figs 4 through 6) . Unlike the CD14' HLA-DR' cells recultured in M-CSF, however, there was no expansion. We therefore considered monocyte development to be the default pathway for terminal differentiation of the day 6 sorted CD14+ HLA-DR' intermediates.
The CD14' HLA-DR+ phenotype does not retain bipotential difSerentiation capacity beyond thejrst 6 to 7 days in suspension culture. Depletion of already mature monocyteslmacrophages by days 6 to 7 of culture in GM-CSF and TNF-a was essential for the subsequent maturation of the sorted CD14+ HLA-DR' intermediates along a dendritic cell pathway. By days 8 to 9 and beyond, mature monocytes/ macrophages were sufficiently developed that CD 14+ HLA-DR+ cells could no longer be isolated with the same bipotential differentiation potential as the double-positive intermediates from day 6 cultures. This is illustrated in Table 2 using day 12 through 14 progeny to stimulate allogeneic T cells in the MLR. Similarly, day 12 through 14 macrophages generated in M-CSF from day 6 CD14+ HLA-DR' intermediates could not become dendritic cells if recultured beyond days 12 through 14 in GM-CSF and TNF-a (not shown). Standard CD 14+ HLA-DR+ blood monocytes/macrophages could also not be transformed into a population of dendritic cells by exposure to GM-CSF and TNF-a, as previously Day 12 through 14 CD14-HLA-DR++'+++ dendritic cells maintained allostimulatory function in GM-CSF and TNFa , but greater than 80% to 90% of the cells died when recultured in M-CSF. along with c-kit ligand to expand clonogenic precursors and increase total cell yields."."
DISCUSSION
CD34' hematopoietic precursors from human BM have been evaluated with a view toward the development of en-
In a prior study of CD34' BM progenitors cultured in these cytokines in semisolid medium," two types of colonies developed. One consisted entirely of dendritic cells. The cells in these CFU-DC derived colonies lacked CD14 and myeloperoxidase but expressed high levels of HLA-DR and stimulating activity in the allogeneic MLR. The other colonies were CFU-GM-derived but contained a minor population (-1 %) of dendritic cells, only when TNF-CY was added to GM-CSF. Dendritic cell colonies did not develop in GM-CSF alone, and GM colonies did not contain even trace numbers of dendritic cells if TNF-CY were not used together with GM-CSF. Another study documented the development of mature, terminally differentiated macrophages and dendritic cells when CD34' BM precursors were cultured for 2 weeks in suspension with these cytokines. In the present experiments an intermediate cell type has been identified that develops by day 6. It can be diverted from a macrophage to a dendritic cell differentiation pathway depending on subsequent cytokine exposure, thus increasing the frequency of dendritic cells among the final progeny.
These experiments have focused on the day 6 progeny of CD34' progenitors, selecting cells on the basis of CD14 and HLA-DR staining. Progeny that appeared to be mature dendritic cells (CD14-HLA-DR"') and monocytes (CD 14' HLA-DR') had developed by day 6. Restricting analysis only to those cells that were intensely HLA-DR positive, CD14-HLA-DR'" cells represented -2% of the day 6 progeny; and percent yields of these extremely HLA-DR bright cells did not increase with an additional week of culture. The cells had all the features of terminally differentiated dendritic cells except relatively higher expression of CDla, CD4, CDI Ib, and CD32. These were large cells that formed many processes, either large veils in suspension culture or stellate dendrites on cytospins. The cells were nonadherent, lacked myeloperoxidase, and stained weakly or nega-For personal use only. on January 1, 2018. by guest www.bloodjournal.org From tively for nonspecific esterase. The cells were also negative for c-fms, expressed the dendritic cell antigen CD83," and displayed high levels of B7 antigens, CD80 and CD86, which are all characteristic of dendritic cells. Strong T-cell responses were also induced with DC:T ratios of 1/1,OOO or less.
However, the pan nonadherent, sorted CD14' HLA-DR' cells proved not to be typical monocytes/macrophages. This was despite their expression of c-fms and phagocytic properties that were comparable to cultured blood macrophages. A large fraction was in cell cycle, as 40% to 50% displayed the Ki-67 nuclear antigen, but clonogenic capacity was no longer detectable. Several characteristic monocyte traits were also absent, eg, morphology (including many cells with cytoplasmic dendrites or veils that are not seen on monocytes/macrophages), strong plastic adherence, and positive staining for myeloperoxidase and nonspecific esterase. These cells also uniformly expressed CD40 as well as some B7 costimulators (CD80, CD86). In addition, these cells were much stronger stimulators than monocytes of primary T cells in allogeneic MLRs. CD14' progeny with allostimulatory activity have recently been identified in 7-day BM cultures by Egner and Hart.24 However, their bipotential differentia-For personal use only. on January 1, 2018. by guest www.bloodjournal.org From Table 2 tion capacity and their relationship to other myeloid cells, specifically monocytes/macrophages, have not been previously shown.
GM-CSF,
. Allostimulatory Capacity of CD14+ HLA-DR' Cells, Tested Immediately Postsort or After Cytokine-Supplemented Reculture
When the CD14+ HLA-DR+ intermediates were recultured with or without exogenous M-CSF, the cells quantitatively gave rise to adherent, large, CD14+, phagocytic macrophages. Expression of HLA-DR did not increase. Costimulatory molecules like CD80 and CD86 were respectively absent and less strongly expressed compared with the same intermediates recultured in GM-CSF and TNF-a. Stimulatory activity in the allogeneic MLR was also weak. However, there was a modest expansion of as much as 2-to 2.5fold in the presence of M-CSF.
In contrast, when the same CD14+ HLA-DR+ intermediate population was recultured in GM-CSF and TNF-a, the cells differentiated almost quantitatively into dendritic cells. These dendritic cell progeny were functionally identical to mature dendritic cells cultured from blood. These cells also expressed CD83 and CD80/CD86; many still expressed CDla, and a minority also had nonspecific esterase activity. Both of the latter features characterize immature dendritic cells or Langerhans cells:6 whereas CD83' is a marker of mature dendritic cells. 25 This likely reflected asynchrony in the cytokine-driven maturation of these cells, as has been observed among the clonogenic CD14-HLA-DR+++ progeny of CFU-DCs.14 Once differentiation from the CD14+ HLA-DR+ intermediate cells had proceeded along either the dendritic cell or monocyte/macrophage pathway, it could not be altered again by cytokines. Dendritic cells died when recultured in M-CSF and did not become macrophages, and macrophages did not become dendritic cells in GM-CSF and TNF-a. Likewise, CD14+ HLA-DR+ cells isolated at days 8 through 9 and beyond, no longer had the same bipotential differentiation capacity and became macrophages regardless of the cytokine milieu. These later CD14' HLA-DR+ cells specifically could not be induced toward dendritic cell development by GM-CSF and TNF-a.
Therefore, these findings indicate that there is a bipotential CD14' HLA-DR+ population in the day 6 progeny of human CD34' BM cells cultured in GM-CSF and TNF-a. The critical question is why does the dendritic cell potential of this intermediate population not develop routinely in the presence of GM-CSF and TNF-a? To observe this dendritic cell pathway, the day 6 cultures had to be depleted of already matured, firmly adherent macrophages and then supplemented with exogenous GM-CSF and TNF-a. Possibly the macrophages exert a suppressive influence on dendritic cell development. Both IL-lO" 3' and transforming growth factor-/3 (TGF-/3)"." are macrophage products reported to have suppressive effects on dendritic cell function. These and other as yet unidentified cytokines warrant continued investigation with respect to inhibiting dendritic cell growth and differentiation from CD14+ HLA-DR+ intermediates.
Several hypotheses can be formulated to reconcile these findings with clonogenic studies of BM-derived human dendritic cells.14 CD14-HLA-DR"' dendritic cells that develop rapidly by day 6 in suspension culture may be equivalent to the progeny of CFU-DC in clonogenic assays.14 CFU-GM have the potential to generate dendritic cells alongside other myeloid progeny, which in the human requires the addition of TNF-a to GM-CSF.I4 TNF-a has pleiotropic effects on hematopoiesis with respect to both cytokines and their receptors, enhancing the recruitment and expansion of less differentiated progenitors while inhibiting the growth of more committed precursor population^.'^-^^ CD 14' HLA-DR' intermediates may be included among the developing progeny of CFU-GM, but their bipotential differentiation capacity would not be as apparent because of the competing influence of simultaneously developing macrophages. Another possibility is that there are not two different CD34' progenitors, one for day 6 CD14-HLA-DR"' dendritic cells and another for day 6 CD14' HLA-DR' intermediates. The potential of a single myeloid progenitor to form dendritic cell colonies may sometimes be blocked by the early development of suppressive macrophages during the stochastic process of lineage commitment from primitive CFUs.
Caux et al4 have also presented evidence for two pathways of dendritic cell development from human CD34+ progenitors in cord blood. By day 5, two intermediates have developed in the presence of GM-CSF and TNF-a. One is CDla+ CD14-and the other is CDla-CD14+. Both give rise to CDla' CD14-dendritic cell progeny after a second For personal use only. on January 1, 2018. by guest www.bloodjournal.org From week in culture with GM-CSF, irrespective of the presence of TNF-a. The CDla+ CD14-intermediates yield Birbeck granule-containing dendriticLangerhans cells of the same phenotype. The CDla-CD14+ intermediates generate progeny characteristic of CDla+ CD14-dermal dendritic cells that lack Birbeck granules. CDla did not prove to be a discriminating marker in marrow, which also differs from cord blood in having a much greater capacity to form macrophages.
The CDla-CD14+ cells in cord blood may be analogous to the CD14+ HLA-DR+ intermediates described here in human BM. This intermediate population has been extensively characterized, including similarities and dissimilarities to standard monocytes, irrespective of the CD14+ phenotype. It has also been distinguished from the CD14-HLA-DR+++ dendritic cells that develop in the same cultures by day 6. This post-CFU, CD14+ HLA-DR+ intermediate population retains bipotential differentiation capacity for either dendritic cells or monocyteshnacrophages. Dendritic cell differentiation is cytokine dependent but can be altered by other cells, most likely mature macrophages that have already developed by day 6 in cytokine-supplemented cultures of human CD34+ BM precursors.
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